KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Profit After Tax: 2010-2025

Historic Profit After Tax for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to -$35.5 million.

  • Nektar Therapeutics' Profit After Tax rose 4.14% to -$35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$120.7 million, marking a year-over-year increase of 28.26%. This contributed to the annual value of -$119.0 million for FY2024, which is 56.91% up from last year.
  • Per Nektar Therapeutics' latest filing, its Profit After Tax stood at -$35.5 million for Q3 2025, which was up 14.60% from -$41.6 million recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Profit After Tax peaked at $7.3 million during Q4 2024, and registered a low of -$159.1 million during Q2 2022.
  • Moreover, its 3-year median value for Profit After Tax was -$42.1 million (2023), whereas its average is -$47.5 million.
  • In the last 5 years, Nektar Therapeutics' Profit After Tax crashed by 56.90% in 2021 and then surged by 117.26% in 2024.
  • Over the past 5 years, Nektar Therapeutics' Profit After Tax (Quarterly) stood at -$145.6 million in 2021, then soared by 59.02% to -$59.7 million in 2022, then rose by 29.50% to -$42.1 million in 2023, then skyrocketed by 117.26% to $7.3 million in 2024, then increased by 4.14% to -$35.5 million in 2025.
  • Its Profit After Tax stands at -$35.5 million for Q3 2025, versus -$41.6 million for Q2 2025 and -$50.9 million for Q1 2025.